Category: Amgen

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX

TAVNEOS® (avacopan), a First-in-Class Drugs for Sufferers With Extreme Energetic ANCA-Related Vasculitis, Added to Irritation Portfolio THOUSAND OAKS, Calif., Oct. 20, 2022 /PRNewswire/ — Amgen (NASDAQ:...